<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1368389</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1368389</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Herbal medical products and natural products targeting aging and age-related disorders--ethnopharmacological perspectives</article-title>
<alt-title alt-title-type="left-running-head">Ullah et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1368389">10.3389/fphar.2024.1368389</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ullah</surname>
<given-names>Hammad</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1851914/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khan</surname>
<given-names>Haroon</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/275480/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prieto Lage</surname>
<given-names>Miguel Angel</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/107688/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Daglia</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1666638/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pharmacy</institution>, <institution>University of Napoli Federico II</institution>, <addr-line>Naples</addr-line>, <country>Italy</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pharmacy</institution>, <institution>Abdul Wali Khan University Mardan</institution>, <addr-line>Mardan</addr-line>, <country>Pakistan</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Universidade de Vigo, Nutrition and Bromatology Group</institution>, <institution>Department of Analytical Chemistry and Food Science</institution>, <institution>Instituto de Agroecolox&#x00ED;a e Alimentaci on (IAA)&#x2013;CITEXVI</institution>, <addr-line>Vigo</addr-line>, <country>Spain</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Centro de Investiga&#xe7;&#xe3;o de Montanha (CIMO)</institution>, <institution>Instituto Polit&#xe9;cnico de Bragan&#xe7;a</institution>, <addr-line>Bragan&#xe7;a</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>International Research Center for Food Nutrition and Safety</institution>, <institution>Jiangsu University</institution>, <addr-line>Zhenjiang</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/439467/overview">Javier Echeverria</ext-link>, University of Santiago, Chile</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/112235/overview">Luca Rastrelli</ext-link>, University of Salerno, Italy</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Maria Daglia, <email>maria.daglia@unina.it</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1368389</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Ullah, Khan, Prieto Lage and Daglia.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Ullah, Khan, Prieto Lage and Daglia</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Pharmacol." xlink:href="https://www.frontiersin.org/researchtopic/49767" ext-link-type="uri">Editorial on the Research Topic <article-title>Herbal medical products and natural products targeting aging and age-related disorders&#x2014;ethnopharmacological perspectives</article-title>
</related-article>
<kwd-group>
<kwd>natural products</kwd>
<kwd>herbal medicines (HM)</kwd>
<kwd>aging</kwd>
<kwd>age-related disorders</kwd>
<kwd>prevention</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ethnopharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The population aged &#x2265;60 years is growing worldwide. The World Health Organization (WHO) reported that the elderly population is expected to increase from 1 billion in 2020 to 1.4 billion in 2030 and 2.1 billion in 2050 (<xref ref-type="bibr" rid="B7">World Health Organization, 2022</xref>). This increase in life expectancy around the globe is accompanied with the enhancing frequency of aging-associated disorders, mainly due to the deterioration of metabolic, circulatory, and immune functioning. Inflammaging (chronic low-grade inflammation) is considered as one of the main drivers of the initiation and progression of diseases such as sarcopenia, osteoporosis, metabolic ailments, atherosclerosis, neurodegenerations, and carcinogenesis (<xref ref-type="bibr" rid="B6">Ullah et al., 2022</xref>). However, the actual etiology of these disorders is complicated due to the complex interaction of genes and environment, making their management more challenging in real-world circumstances. Currently, pharmacological interventions remained the mainstream option for the treatment of age-related diseases although drugs are associated with increased risk of the occurrence of adverse effects due to the increased susceptibility of adult population to drug effects, altered pharmacokinetic parameters, and use of polypharmacy, which may also increase the likelihood of drug interactions (<xref ref-type="bibr" rid="B1">Baldoni et al., 2010</xref>; <xref ref-type="bibr" rid="B4">Goldberg et al., 2022</xref>; <xref ref-type="bibr" rid="B5">Kwak et al., 2022</xref>).</p>
<p>Natural products from terrestrial and marine sources have been of great interest in the field of aging and age-related disorders due to their potential health-promoting properties. Extensive literature data have reported a wide range of natural products for the prevention and/or treatment of most challenging diseases. While the research in this area is ongoing, some natural products have shown promising properties in contributing to healthy aging and potentially mitigating age-related disorders. It is important to note that the effectiveness of these products may vary, and more research is needed to establish their therapeutic benefits (<xref ref-type="bibr" rid="B3">C&#x103;tan&#x103; et al., 2018</xref>; <xref ref-type="bibr" rid="B2">Bj&#xf8;rklund et al., 2022</xref>). In this context the current Research Topic &#x201c;Herbal medical products and natural products targeting aging and age-related disorders&#x2013;ethnopharmacological perspectives&#x201d; is designed to focus on the preclinical and clinical research updates on the chemically-characterized botanical extracts, derived phytochemicals, and food bioactive ingredients targeting aging and age-related disorders (such as metabolic, cardiovascular, neurological, and bone diseases, and cancer), and their mechanistic targets with reference to age-related disorders including cellular aging signaling. The main aim of this Research Topic was to identify natural products with health-span and longevity-promoting effects.</p>
<p>A total of six articles including two original research (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcvm.2023.1126573">Xu et al.</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1212376">Subramanian et al.</ext-link>) and four literature reviews (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1192714">Gao et al.</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1236893">Chen et al.</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1252907">Jing et al.</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1303902">Ma et al.</ext-link>) were published. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcvm.2023.1126573">Xu et al.</ext-link> investigated the effects of Chinese traditional herb (<italic>T. pericarpium</italic>) in improving microcirculation in patients with acute myocardial infarction following percutaneous coronary intervention. The results of this study demonstrated significant improvement in coronary microcirculation in <italic>Trichosanthes pericarpium</italic> treated patients as suggested by the decrease in corrected thrombolysis in myocardial infarction frame count (CTFC), index of microcirculatory resistance (IMR), and major adverse cardiac events, with an improvement in left ventricular ejection fraction and left ventricular internal dimension. While evaluating the neuroprotective potential of <italic>M. quadrifolia</italic> Linn. in rodents, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1212376">Subramanian et al.</ext-link> observed the amelioration of monosodium glutamate-induced excitotoxicity in rats with quercetin-enriched <italic>Marsilea quadrifolia</italic> extract. The main effects included the reduced locomotor score and impaired memory/learning, increased blood levels of sodium and calcium, and less neuronal disorganization along with cerebral edema and neuronal degeneration.</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1192714">Gao et al.</ext-link> reviewed and summarized the available literature on the antiaging potential of polyphenols (quercetin, luteolin, catechins, resveratrol, curcumin, and lignans), saponins, alkaloids, and polysaccharides. The cellular and molecular targets mediating the longevity-extending effects of these products include sirtuin, AMP-activated protein kinase (AMPK), mammalian target of rapamycin (mTOR), p53, and insulin/insulin-like growth factor-1 signaling pathways. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1236893">Chen et al.</ext-link> reviewed a literature to highlight the protective effects of natural coumarin osthole against osteoporosis. It was reported that osthole may enhance the osteoblast-related bone formation with a decreased osteoclast-related bone resorption and suppressed osteoporosis-related fragility fracture. The mechanistic targets of osthole may include activation of Wnt/&#x3b2;-catenin and BMP-2/Smad1/5/8 signaling pathways to promote osteogenic differentiation and suppressions of RANKL-induced osteoclast activity. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1252907">Jing et al.</ext-link> discussed the natural products modulating the crosstalk between gut microbiota and immune response in atherosclerosis, as it has been reported over the past decades that gut microbiota and its metabolites regulate the functional expression of immune cells, possessing a considerable impact on the progression of atherosclerosis. Natural products such as polyphenols, alkaloids, and saponins are found to modulate the relative abundance of gut microbiota, which may result in delaying the progression of atherosclerosis, suppressing the monocytes/macrophages migration, downstream regulation of inflammatory mediators, regulation of Treg/Th17 balance, and suppressing the foam cells formation. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1303902">Ma et al.</ext-link> provided a comprehensive review on the Tibetan medicine Shengdeng (rich in flavonoids and triterpenoids) including their traditional uses and reported pharmacological uses including antioxidant, anti-inflammatory, antimicrobial, anti-arthritic, and anti-cancer activities.</p>
<p>In conclusion, this Research Topic collects articles on herbal extracts and isolated compounds with potential antiaging effects, supporting the fact that natural products may serve as a sustainable source of chemical entities promoting healthy aging and counteracting age-related diseases. However, it is essential to approach the use of natural products with caution and after consult with qualified healthcare professionals before incorporating them into a routine practice, particularly in the context of managing age-related disorders. Moreover, pharmacokinetic and toxicity studies should be conducted to further establish the efficacy and safety of these products.</p>
</sec>
</body>
<back>
<sec id="s2">
<title>Author contributions</title>
<p>HU: Conceptualization, Methodology, Writing&#x2013;original draft, Writing&#x2013;review and editing. HK: Writing&#x2013;review and editing. MP: Writing&#x2013;review and editing. MD: Writing&#x2013;review and editing, Conceptualization.</p>
</sec>
<sec sec-type="funding-information" id="s3">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="s4">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s5">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldoni</surname>
<given-names>A. D. O.</given-names>
</name>
<name>
<surname>Chequer</surname>
<given-names>F. M. D.</given-names>
</name>
<name>
<surname>Ferraz</surname>
<given-names>E. R. A.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>D. P. D.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>L. R. L.</given-names>
</name>
<name>
<surname>Dorta</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Elderly and drugs: risks and necessity of rational use</article-title>. <source>Braz J. Pharm. Sci.</source> <volume>46</volume>, <fpage>617</fpage>&#x2013;<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1590/s1984-82502010000400003</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bj&#xf8;rklund</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shanaida</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lysiuk</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Butnariu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sarac</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Natural compounds and products from an anti-aging perspective</article-title>. <source>Molecules</source> <volume>27</volume>, <fpage>7084</fpage>. <pub-id pub-id-type="doi">10.3390/molecules27207084</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>C&#x103;tan&#x103;</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Atanasov</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Berindan-Neagoe</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Natural products with anti-aging potential: affected targets and molecular mechanisms</article-title>. <source>Biotechnol. Adv.</source> <volume>36</volume>, <fpage>1649</fpage>&#x2013;<lpage>1656</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.03.012</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldberg</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>S. U.</given-names>
</name>
<name>
<surname>Britton</surname>
<given-names>W. B.</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Prevalence of meditation-related adverse effects in a population-based sample in the United States</article-title>. <source>Psychother. Res.</source> <volume>32</volume>, <fpage>291</fpage>&#x2013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1080/10503307.2021.1933646</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwak</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goyal</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Hummel</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Dhoble</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Medication complexity among older adults with HF: how can we assess better?</article-title> <source>Drugs Aging</source> <volume>39</volume>, <fpage>851</fpage>&#x2013;<lpage>861</lpage>. <pub-id pub-id-type="doi">10.1007/s40266-022-00979-2</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ullah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Daglia</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The focus on foods for special medical purposes and food supplements in age&#x2010;related disorders</article-title>. <source>Food Front.</source> <volume>3</volume>, <fpage>353</fpage>&#x2013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1002/fft2.163</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="web">
<collab>World Health Organization</collab> (<year>2022</year>). <article-title>Ageing and health</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/ageing-and-health">https://www.who.int/news-room/fact-sheets/detail/ageing-and-health</ext-link> (Accessed January 3, 2024)</comment>.</citation>
</ref>
</ref-list>
</back>
</article>